MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer

Approximately half of the colorectal cancer (CRC) patients develop metastatic disease. Fluoropyrimidine-based chemotherapy forms the backbone of treatment in these patients. However, the response to this therapy varies between individuals. Therefore, an important challenge in CRC research is to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Simmer, Femke, Venderbosch, Sabine, Dijkstra, Jeroen R., Vink-Börger, Elisa M., Faber, Claudius, Mekenkamp, Leonie J., Koopman, Miriam, De Haan, Anton F., Punt, Cornelis J., Nagtegaal, Iris D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673216/
https://www.ncbi.nlm.nih.gov/pubmed/26392389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673216/
https://www.ncbi.nlm.nih.gov/pubmed/26392389

Ejemplares similares